BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27804156)

  • 1. Transfemoral Transcatheter Aortic Valve Implantation: How Minimalistic Can We Become?
    Sawaya FJ; Lefèvre T; Spaziano M; Roy A; Fernandez L; Garot P; Chevalier B; Hovasse T
    J Interv Cardiol; 2016 Dec; 29(6):628-631. PubMed ID: 27804156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning.
    Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
    Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A feasibility study of transaxillary TAVI with the lotus valve.
    Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrograde Femoral Artery Stent-Graft Implantation for Treatment of Access-site Bleeding Following Transcatheter Aortic Valve Implantation.
    Sliman H; Shiran A; Mannheim D; Avraham E; Karmeli R; Khader N; Zafrir B; Rubinshtein R; Jaffe R
    Isr Med Assoc J; 2019 May; 21(5):322-325. PubMed ID: 31140223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Taramasso M; Denegri A; Kuwata S; Rickli H; Haager PK; Sütsch G; Rodriguez Cetina Biefer H; Kottwitz J; Nietlispach F; Maisano F
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):533-539. PubMed ID: 28500739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distal Radial Secondary Access for Transcatheter Aortic Valve Implantation: The Minimalistic Approach.
    Achim A; Szűcsborus T; Sasi V; Nagy F; Jambrik Z; Nemes A; Varga A; Bertrand OF; Ruzsa Z
    Cardiovasc Revasc Med; 2022 Jul; 40():152-157. PubMed ID: 34848177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trial.
    Durand E; Le Breton H; Lefevre T; Gilard M; Himbert D; Alcazar MU; Bettinger N; Auffret V; Didier R; Chevalier B; Béziau DM; Iung B; Eltchaninoff H
    Arch Cardiovasc Dis; 2020; 113(6-7):391-400. PubMed ID: 32418883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes.
    Kallinikou Z; Berger A; Ruchat P; Khatchatourov G; Fleisch I; Korkodelovic B; Henchoz E; Marti RA; Cook S; Togni M; Goy JJ
    Arch Cardiovasc Dis; 2017; 110(6-7):389-394. PubMed ID: 28433509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation.
    Schäfer U; Schirmer J; Niklas S; Harmel E; Deuschl F; Conradi L
    EuroIntervention; 2017 Dec; 13(11):1296-1299. PubMed ID: 28846544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transradial Secondary Access to Guide Valve Implantation and Manage Peripheral Vascular Complications During Transcatheter Aortic Valve Implantation.
    Jackson MWP; Muir DF; de Belder MA; Palmer S; Owens WA; Goodwin A; Hayat U; Williams PD
    Heart Lung Circ; 2019 Apr; 28(4):637-646. PubMed ID: 29685717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of the transsubclavian approach for transcatheter aortic valve implantation with the 14-F CoreValve Evolut R device.
    Anselmi A; Tomasi J; Giardinelli F; Bedossa M; Rosier S; Verhoye JP
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):664-668. PubMed ID: 30299409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
    Amat-Santos IJ; Rojas P; Gutiérrez H; Vera S; Castrodeza J; Tobar J; Goncalves-Ramirez LR; Carrasco M; Catala P; San Román JA
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):935-944. PubMed ID: 29314570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirty-Day Outcomes in 100 Consecutive Patients Undergoing Transfemoral Aortic Valve Replacement With the Portico Valve on an All-Comer Basis.
    Mas-Peiro S; Vasa-Nicotera M; Weiler H; Papadopoulos N; De Rosa R; Zeiher AM; Fichtlscherer S
    J Invasive Cardiol; 2017 Dec; 29(12):431-436. PubMed ID: 29207365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfemoral transcatheter aortic valve implantation for treatment of severe aortic regurgitation in a patient with previous aortic valve-sparing operation according to David.
    Favero L; De Leo A; Daniotti A; Calzolari D; Gasparetto N; Minniti G; Polesel E; Olivari Z
    Cardiovasc Revasc Med; 2017 Dec; 18(8):611-615. PubMed ID: 28779858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfemoral aortic valve implantation after cardiac transplantation.
    Andrási TB; Danner BC; Grossmann M; Schöndube FA; HASENFUß G; Jacobshagen C
    J Cardiovasc Surg (Torino); 2018 Feb; 59(1):143-145. PubMed ID: 29231677
    [No Abstract]   [Full Text] [Related]  

  • 20. Suprasternal Transcatheter Aortic Valve Replacement in Patients With Marginal Femoral Access.
    Kiser AC; Caranasos TG; Peterson MD; Holzhey DM; Kiefer P; Nifong LW; Borger MA
    Innovations (Phila); 2018; 13(1):1-4. PubMed ID: 29462049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.